Skip to main content
SpringerLink
Log in

Addressing shortages and rising prices of off-patent drugs in the US

  • Unknown
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Gupta R, et al. Affordability and availability of off-patent drugs in the United States - the case for importing from abroad: observational study. BMJ : 19 Mar 2018. Available from: URL: https://doi.org/10.1136/bmj.k831

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Addressing shortages and rising prices of off-patent drugs in the US. PharmacoEcon Outcomes News 799, 7 (2018). https://doi.org/10.1007/s40274-018-4789-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4789-2

Search

Navigation